… Cardiac allograft vasculopathy remains a troublesome long-… the vascular bed of the allograft,
including the donor aortic … reinnervation of the cardiac allografts, most heart transplant …

… Retransplantation as a transplant indication is not common in the pediatric population and
makes up approximately 5% of total transplants in North America and even less in Europe …

… Coronary allograft vasculopathy (CAV) is the leading cause of death after pediatric heart …
North America. We performed a comparative study using intravascular ultrasound (IVUS). …

… Cardiac allograft vasculopathy (CAV) continues to limit the … However, because individual
responses to an allograft … rejection, accelerated cardiac allograft vasculopathy (CAV) still limits …

… Conversely, cardiac allograft vasculopathy is associated with … However, even though cardiac
allograft vasculopathy … cardiac allografts, indicating that cardiac allograft vasculopathy can …

… This study investigated temporal changes in the demographics and the prognosis of
cardiac allograft vasculopathy (CAV) over 30 years following heart transplantation (HTx). …

… Cardiac allograft vasculopathy (CAV) is an important cause of morbidity and mortality among
… the concentric intimal hyperplasia commonly seen in cardiac allograft vasculopathy (CAV). …

… However, unusually high restenosis rates (55% at 8 months) were reported in the North
American Multicenter Registry.As regards the treatment of CAV with coronary artery stenting, …

Objectives : The goal of this study was to examine the outcomes of percutaneous coronary
interventions (PCI) and the predictors for restenosis after cardiac transplantation. Background …

… sites throughout North America and the United Kingdom and is expanding to other continents.
At the time of this analysis, the data were contributed by 50 North American transplant …